Benvenue Medical will present positive interim results of a retrospective analysis of its Luna 3D Multi-Expandable Interbody Fusion System at Spine Summit 2018 taking place March 14-17 in Orlando.
Here are four things to know.
1. The single-center, minimally invasive study evaluated the safety and efficacy of the Luna device when placed from a standard minimally invasive transforaminal lumbar interbody fusion approach.
2. The retrospective analysis assessed 31 patients treated with the Luna 3D System who had at least six months of postoperative follow up. All but one patient experienced improvement in baseline pain scores and disability scores improved for all patients. Spondylolisthesis was reduced significantly when present. There were no instances of graft subsidence or hardware failure.
3. The Luna 3D System is comprised of a PEEK implant intended to expand in multiple dimensions within the disc space, first in footprint, second in height and third in lordosis, enabling surgeons to restore sagittal balance and height through a MIS posterior approach while providing the stability of a larger construct usually associated with an anterior approach.
4. Post-discectomy, the Luna 3D Implant is delivered through a small diameter cannula into the disc space. After expanding its footprint, it then expands in height and lordosis with the insertion of a middle section. When the cannula is removed, a large volume of bone graft is placed in the middle of the implant to enable an interbody fusion.
More articles on surface technology:
5 spine surgeons on the future of implant technology & material
Amedica earns FDA clearance for Valeo C+CSC with Lumen Interbody Fusion Device — 5 notes
Stryker receives FDA clearance for 3-D printed tritanium lumbar cage: 5 notes